Sign in
4

Changes in Ownership

HALOZYME THERAPEUTICS, INC. Filed Acc 0001179110-21-007391

SVP, Chief Technical Officer sold 40,315 shares at $45.70 ($1,842,315)

  • SVP, Chief Technical Officer acquired 40,315 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

LaBarre Michael J. · SVP, Chief Technical Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-07-01 Exercise or conversion : show line 1 in the form +40,315 $6.55 $264,063 174,426 D
2021-07-01 Sale : show line 2 in the form −40,315 $45.70 $1,842,315 134,111 D
Open-market sales · 40,315 sh · avg $45.70 · $1,842,315

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2021-07-01 Exercise or conversion : show line 3 in the form Option to Purchase Common Stock −40,315 $6.55 2023-02-04 40,315 14,685 D
Loading xslF345X03/edgar.xml…